“TP53, ETV6 and RUNX1 germline variants in a case series of patients developing secondary neoplasms after treatment for childhood acute lymphoblastic leukemia”
In this letter-to-the-editor article, published in the journal “Haematologica”, TP53, ETV6 and RUNX1 genes were analyzed to characterize their potential impact on second neoplasia development after ALL therapy in childhood. A click on the following Button takes you directly to the article.